Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8929453rdf:typepubmed:Citationlld:pubmed
pubmed-article:8929453lifeskim:mentionsumls-concept:C0104998lld:lifeskim
pubmed-article:8929453lifeskim:mentionsumls-concept:C0020204lld:lifeskim
pubmed-article:8929453lifeskim:mentionsumls-concept:C0167627lld:lifeskim
pubmed-article:8929453lifeskim:mentionsumls-concept:C0041904lld:lifeskim
pubmed-article:8929453lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:8929453lifeskim:mentionsumls-concept:C1705431lld:lifeskim
pubmed-article:8929453lifeskim:mentionsumls-concept:C0883208lld:lifeskim
pubmed-article:8929453lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:8929453lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:8929453pubmed:issue1lld:pubmed
pubmed-article:8929453pubmed:dateCreated1996-12-23lld:pubmed
pubmed-article:8929453pubmed:abstractTextThe upregulation of costimulatory molecules of antigen presenting cells (APC) resulting from interaction with activated T cells was studied in an in vitro system composed of well-characterized murine T hybridomas and B cell lymphomas. Increased B7-1 expression was induced on both MHC-matched and -mismatched (bystander) B lymphoma cells present in cultures of activated T hybridomas. Identical results were obtained with T hybridomas activated by either the appropriate peptide presented by MHC-matched APC or by mitogen stimulation in the absence of MHC/TCR cognate interactions. Soluble factors alone did not lead to upregulation of B7-1; B lymphomas cultured on the opposite side of a transwell membrane from an ongoing T cell stimulation response, or in supernatants of activated T cells, did not exhibit enhanced expression of B7-1. Antibodies to the CD40 ligand (CD40L) of T cells inhibited the increased appearance of B7-1 on B lymphomas. Significant B7-1 upregulation on the population of bystander B cells could be achieved even when they were present at a 10:1 excess over MHC-matched APC. These data indicate that B7-1 upregulation results from contact between bystander B cells and activated T hybridomas in vitro by CD40-CD40L interaction, without the requirement for TCR/MHC interaction.lld:pubmed
pubmed-article:8929453pubmed:languageenglld:pubmed
pubmed-article:8929453pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8929453pubmed:citationSubsetIMlld:pubmed
pubmed-article:8929453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8929453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8929453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8929453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8929453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8929453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8929453pubmed:statusMEDLINElld:pubmed
pubmed-article:8929453pubmed:monthNovlld:pubmed
pubmed-article:8929453pubmed:issn0008-8749lld:pubmed
pubmed-article:8929453pubmed:authorpubmed-author:JonesK WKWlld:pubmed
pubmed-article:8929453pubmed:authorpubmed-author:HackettC JCJlld:pubmed
pubmed-article:8929453pubmed:issnTypePrintlld:pubmed
pubmed-article:8929453pubmed:day25lld:pubmed
pubmed-article:8929453pubmed:volume174lld:pubmed
pubmed-article:8929453pubmed:ownerNLMlld:pubmed
pubmed-article:8929453pubmed:authorsCompleteYlld:pubmed
pubmed-article:8929453pubmed:pagination42-53lld:pubmed
pubmed-article:8929453pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:8929453pubmed:meshHeadingpubmed-meshheading:8929453-...lld:pubmed
pubmed-article:8929453pubmed:meshHeadingpubmed-meshheading:8929453-...lld:pubmed
pubmed-article:8929453pubmed:meshHeadingpubmed-meshheading:8929453-...lld:pubmed
pubmed-article:8929453pubmed:meshHeadingpubmed-meshheading:8929453-...lld:pubmed
pubmed-article:8929453pubmed:meshHeadingpubmed-meshheading:8929453-...lld:pubmed
pubmed-article:8929453pubmed:meshHeadingpubmed-meshheading:8929453-...lld:pubmed
pubmed-article:8929453pubmed:meshHeadingpubmed-meshheading:8929453-...lld:pubmed
pubmed-article:8929453pubmed:meshHeadingpubmed-meshheading:8929453-...lld:pubmed
pubmed-article:8929453pubmed:meshHeadingpubmed-meshheading:8929453-...lld:pubmed
pubmed-article:8929453pubmed:meshHeadingpubmed-meshheading:8929453-...lld:pubmed
pubmed-article:8929453pubmed:meshHeadingpubmed-meshheading:8929453-...lld:pubmed
pubmed-article:8929453pubmed:meshHeadingpubmed-meshheading:8929453-...lld:pubmed
pubmed-article:8929453pubmed:meshHeadingpubmed-meshheading:8929453-...lld:pubmed
pubmed-article:8929453pubmed:meshHeadingpubmed-meshheading:8929453-...lld:pubmed
pubmed-article:8929453pubmed:meshHeadingpubmed-meshheading:8929453-...lld:pubmed
pubmed-article:8929453pubmed:meshHeadingpubmed-meshheading:8929453-...lld:pubmed
pubmed-article:8929453pubmed:meshHeadingpubmed-meshheading:8929453-...lld:pubmed
pubmed-article:8929453pubmed:year1996lld:pubmed
pubmed-article:8929453pubmed:articleTitleActivated T hybridomas induce upregulation of B7-1 on bystander B lymphoma cells by a contact-dependent interaction utilizing CD40 ligand.lld:pubmed
pubmed-article:8929453pubmed:affiliationImmuLogic Pharmaceutical Corporation, Waltham, Massachusetts 02154, USA.lld:pubmed
pubmed-article:8929453pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8929453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8929453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8929453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8929453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8929453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8929453lld:pubmed